Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival

Takao Kamai(Dokkyo University), Ken‐Ichiro Yoshida(Dokkyo Medical University)
Cancer Immunology Immunotherapy
January 8, 2021
10.1007/s00262-020-02843-x
Cited by 39

Related Papers

Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma
|BMC Cancer|2013|71
Higher preoperative serum levels of <scp>PD</scp>‐L1 and B7‐H4 are associated with invasive and metastatic potential and predictable for poor response to <scp>VEGF</scp>‐targeted therapy and unfavorable prognosis of renal cell carcinoma
|Cancer Medicine|2016|52
Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma
|Cancer Immunology Immunotherapy|2011|18
Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density
|Cancer Immunology Immunotherapy|2020|16
Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report
|OncoTargets and Therapy|2014|8